In other words, 90% of initial demand from all new patient attempts go unrealized, signifying significant patient leakage
A: Yes, according to FDA prescribing information, all GLP-1 medications available through Ro are administered as subcutaneous (under-skin) injections: Frequency : Once weekly (same day each week) Injection sites : Abdomen, thigh, or upper arm (rotate sites) Needle size : Very small (similar to insulin needles) Administration time : Less than 1 minute Most members report that injection anxiety diminishes significantly after first few doses
Nearly all common side effects are manageable, time-limited, and predictable enough to plan around
What legitimate weight loss research looks like For context, let us examine what genuine weight loss peptide research involves
In the STEP 1 trial, approximately 44% of participants in the Wegovy group reported nausea at some point during treatment
Telling her to "just take the medication" dismisses the importance of breastfeeding